X T L Biopharmaceuticals reported $5.44M in Equity Capital and Reserves for its fiscal quarter ending in December of 2024.


Equity Capital And Reserves Change Date
Alaunos Therapeutics USD 2.06M 661K Dec/2024
Bioline Rx USD 20.07M 792K Jun/2025
Teva Pharmaceutical Industries USD 6.83B 572M Jun/2025
X T L Biopharmaceuticals USD 5.44M 282K Dec/2024